Jupiter Life Line Hospitals Future Growth
Future criteria checks 3/6
Jupiter Life Line Hospitals is forecast to grow earnings and revenue by 18.6% and 14.6% per annum respectively. EPS is expected to grow by 18.9% per annum. Return on equity is forecast to be 16.5% in 3 years.
Key information
18.6%
Earnings growth rate
18.9%
EPS growth rate
| Healthcare earnings growth | 27.3% |
| Revenue growth rate | 14.6% |
| Future return on equity | 16.5% |
| Analyst coverage | Low |
| Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 17,182 | 2,921 | 1,061 | 3,402 | 5 |
| 3/31/2026 | 14,846 | 2,561 | 444 | 2,941 | 5 |
| 3/31/2025 | 12,750 | 2,063 | 556 | 2,570 | 5 |
| 9/30/2024 | 12,076 | 1,850 | -796 | 1,598 | N/A |
| 6/30/2024 | 11,427 | 1,672 | N/A | N/A | N/A |
| 3/31/2024 | 10,955 | 1,766 | 292 | 1,145 | N/A |
| 12/31/2023 | 10,418 | 1,471 | N/A | N/A | N/A |
| 9/30/2023 | 9,919 | 1,031 | N/A | N/A | N/A |
| 6/30/2023 | 9,486 | 965 | N/A | N/A | N/A |
| 3/31/2023 | 9,030 | 729 | 399 | 1,172 | N/A |
| 3/31/2022 | 7,371 | 511 | 452 | 1,370 | N/A |
| 3/31/2021 | 4,903 | 22 | -1,182 | 1,234 | N/A |
| 3/31/2020 | 4,629 | 296 | 456 | 742 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 543980's forecast earnings growth (18.6% per year) is above the savings rate (6.7%).
Earnings vs Market: 543980's earnings (18.6% per year) are forecast to grow faster than the Indian market (18% per year).
High Growth Earnings: 543980's earnings are forecast to grow, but not significantly.
Revenue vs Market: 543980's revenue (14.6% per year) is forecast to grow faster than the Indian market (10.4% per year).
High Growth Revenue: 543980's revenue (14.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 543980's Return on Equity is forecast to be low in 3 years time (16.5%).